In the hypertension and the OSA-plus-hypertension groups, the percentage of patients who were receiving diuretics, β-blockers, calcium-channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor antagonists was similar (data not shown). Here, ACE is linked to obstructive sleep apnea syndrome.